Form D · Other Health Care

RxLightning, Inc.

New Albany, IN · CIK 0001856495

Offering snapshot reported Jun 6, 2023 · SEC filing

Reported sold
$17.5M
Offering amount: $17.5M
Investors reported
12
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 25, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 6, 2023Initial$17,499,950No comparison12SEC filing
Apr 15, 2022Initial$5,350,000No comparison7SEC filing
Apr 27, 2021Amendment$3,000,000No comparisonNot reportedSEC filing
Apr 16, 2021Initial$2,000,000No comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-483473
Total Amount Sold also includes the conversion of previously issued Simple Agreements for Future Equity (SAFEs).

Source: Form D, filed Jun 6, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Brad Allen Executive
Mark Bakken Director
Kathleen Bresette Executive
Richard Cohan Director
Bradley Fluegel Director
Josh Flum Director
Taha Jangda Director
Jared Klingeisen Executive
Julia Regan Director, Executive, Promoter
Carrie Williams Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
227 Pearl Street
New Albany, IN, 47150